Michael T. Tetzlaff

24.1k total citations
230 papers, 5.8k citations indexed

About

Michael T. Tetzlaff is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, Michael T. Tetzlaff has authored 230 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Oncology, 73 papers in Molecular Biology and 64 papers in Dermatology. Recurrent topics in Michael T. Tetzlaff's work include Cutaneous Melanoma Detection and Management (56 papers), Melanoma and MAPK Pathways (43 papers) and Cancer Immunotherapy and Biomarkers (42 papers). Michael T. Tetzlaff is often cited by papers focused on Cutaneous Melanoma Detection and Management (56 papers), Melanoma and MAPK Pathways (43 papers) and Cancer Immunotherapy and Biomarkers (42 papers). Michael T. Tetzlaff collaborates with scholars based in United States, Australia and Canada. Michael T. Tetzlaff's co-authors include Víctor G. Prieto, Jonathan L. Curry, Carlos A. Torres‐Cabala, Madeleine Duvic, Priyadharsini Nagarajan, Doina Ivan, Adi Diab, Phyu P. Aung, Xiaowei Xu and Jennifer A. Wargo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Michael T. Tetzlaff

223 papers receiving 5.7k citations

Peers

Michael T. Tetzlaff

ONCOL

DERMA

IMMUN

EPIDE

Eduardo Nagore Spain

Douglas R. Fullen United States

Hong Wu United States

William Damsky United States

Kojo S.J. Elenitoba‐Johnson United States

Thomas Wiesner Austria

Ulrich Schwab United Kingdom

Jennifer M. McNiff United States

Pierre Brousset France

Walter C. Darbonne United States

Eduardo Nagore Spain

Michael T. Tetzlaff

2.9k ×1.0

ONCOL

2.1k ×1.0

1.9k ×1.6

DERMA

578 ×0.5

IMMUN

1.4k ×1.6

EPIDE

Citations per year, relative to Michael T. Tetzlaff Michael T. Tetzlaff (= 1×) peers Eduardo Nagore

Countries citing papers authored by Michael T. Tetzlaff

Since Specialization

Citations

This map shows the geographic impact of Michael T. Tetzlaff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Tetzlaff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Tetzlaff more than expected).

Fields of papers citing papers by Michael T. Tetzlaff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael T. Tetzlaff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Tetzlaff. The network helps show where Michael T. Tetzlaff may publish in the future.

Co-authorship network of co-authors of Michael T. Tetzlaff

This figure shows the co-authorship network connecting the top 25 collaborators of Michael T. Tetzlaff. A scholar is included among the top collaborators of Michael T. Tetzlaff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael T. Tetzlaff. Michael T. Tetzlaff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deutsch, Julie S., Tricia R. Cottrell, Krista Y. Chen, et al.. (2024). Pan-tumor harmonization of pathologic response assessment for standardized data collection in neoadjuvant IO trials (PATHdata): Final analysis of a multi-institutional reproducibility study.. Journal of Clinical Oncology. 42(16_suppl). 2515–2515.

Haugh, Alexandra M., Robert C. Osorio, R François, et al.. (2024). Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive Alterations. Cancers. 16(7). 1347–1347. 1 indexed citations

Ronen, Shira, Jonathan L. Curry, Priyadharsini Nagarajan, et al.. (2023). Phenotypic switch in mycosis fungoides: A tertiary cancer center experience. Human Pathology. 142. 27–33.

Schvartsman, Gustavo, Diana Bell, M. Laura Rubin, et al.. (2021). The tumor immune contexture of salivary duct carcinoma. Head & Neck. 43(4). 1213–1219. 10 indexed citations

Qin, Yong, Kathryn Bollin, Mariana Petaccia de Macêdo, et al.. (2020). Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy. Journal for ImmunoTherapy of Cancer. 8(2). e000960–e000960. 37 indexed citations

Pundole, Xerxes, Michael T. Tetzlaff, Michelle D. Williams, et al.. (2020). Osteonecrosis of the Jaw Induced by Treatment with Anti-PD-1 Immunotherapy: A Case Report. Immunotherapy. 12(17). 1213–1219. 6 indexed citations

Bentebibel, Salah-Eddine, Michael E. Hurwitz, Chantale Bernatchez, et al.. (2019). A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors. Cancer Discovery. 9(6). 711–721. 169 indexed citations

Johnson, Daniel H., Anisha B. Patel, Marc Uemura, et al.. (2019). IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy. Cancer Immunology Research. 7(6). 860–865. 91 indexed citations

Aung, Phyu P., Edwin R. Parra, Souptik Barua, et al.. (2019). B7-H3 Expression in Merkel Cell Carcinoma–Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density. Clinical Cancer Research. 25(11). 3455–3467. 29 indexed citations

10.

Vishnoi, Monika, Debasish Boral, Haowen Liu, et al.. (2018). Targeting USP7 Identifies a Metastasis-Competent State within Bone Marrow–Resident Melanoma CTCs. Cancer Research. 78(18). 5349–5362. 36 indexed citations

11.

Sagiv, Oded, Jonathan L. Curry, Jing Ning, et al.. (2018). High expression of PD-1 and PD-L1 in ocular adnexal sebaceous carcinoma. OncoImmunology. 7(9). e1475874–e1475874. 23 indexed citations

12.

Adam, Liana, F. Anthony San Lucas, Richard Fowler, et al.. (2018). DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway. Clinical Cancer Research. 25(2). 641–651. 19 indexed citations

13.

Tetzlaff, Michael T., Jonathan L. Curry, Jing Ning, et al.. (2018). Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations. Clinical Cancer Research. 25(4). 1280–1290. 41 indexed citations

14.

Lefrançois, Philippe, Pingxing Xie, Linghua Wang, et al.. (2018). Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients. OncoImmunology. 7(8). e1467856–e1467856. 23 indexed citations

15.

Tetzlaff, Michael T., Priyadharsini Nagarajan, Susan Y. Chon, et al.. (2017). Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features. American Journal of Dermatopathology. 39(2). 121–129. 82 indexed citations

16.

Feldmeyer, Laurence, Courtney W. Hudgens, Priyadharsini Nagarajan, et al.. (2016). Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma. Clinical Cancer Research. 22(22). 5553–5563. 86 indexed citations

17.

Estrella, Jeannelyn S., Michael T. Tetzlaff, Roland L. Bassett, et al.. (2015). Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing. Molecular Cancer Therapeutics. 14(12). 2887–2895. 33 indexed citations

18.

Chen, Guo, Nitin Chakravarti, Kimberly Aardalen, et al.. (2014). Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target. Clinical Cancer Research. 20(21). 5537–5546. 120 indexed citations

19.

Bucheit, Amanda D., Guo Chen, Alan Siroy, et al.. (2014). Complete Loss of PTEN Protein Expression Correlates with Shorter Time to Brain Metastasis and Survival in Stage IIIB/C Melanoma Patients with BRAF V600 Mutations. Clinical Cancer Research. 20(21). 5527–5536. 109 indexed citations

20.

Zhao, Chengquan, S. Barron, Haijun Zhou, et al.. (2013). Dermatopathology. Laboratory Investigation. 93. 110–125. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact